Nephritic Syndrome Flashcards

1
Q

… syndrome is classically described as the presence of haematuria, variable proteinuria, renal impairment, and hypertension.

A

Nephritic syndrome is classically described as the presence of haematuria, variable proteinuria, renal impairment, and hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The nephritic syndrome describes a very classic presentation of glomerular disease that is characterised by

A

Haematuria
Variable proteinuria (may be nephrotic range)
Renal impairment
Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The cause of nephritic syndrome is commonly differentiated based on the underlying mechanism.

A

Glomerular inflammation is the hallmark of nephritic syndrome. This may be due to inflammation of the small vessels within the capillary tuft (i.e. vasculitis), immune complex deposition or formation of anti-glomerular basement membrane (GBM) autoantibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Immune complex deposition

NEPHRITIC SYNDROME

A

Systemic lupus erythematosus (i.e. lupus nephritis)
Post-streptococcal glomerulonephritis (PSGN)
IgA Nephropathy
Cyroglobulinaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ANCA-associated vasculitis is an umbrella term for three conditions:

A

Microscopic polyangiitis (MPA)
Granulomatosis with polyangiitis (GPA): previously known as Wegener’s granulomatosis
Eosinophilic granulomatosis with polyangiitis (EGPA): previously known as Churg-Strauss syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Small vessel vasculitis

A

This is characterised by very limited or no immune deposition in the glomeruli. Instead, patients usually have circulating autoantibodies known an anti-neutrophil cytoplasmic antibody (ANCA). These autoantibodies target self-antigens leading to a vasculitis (inflammation of arterioles, capillaries & venules) that may be limited to the kidneys or multisystem.

ANCA-associated vasculitis is an umbrella term for three conditions:

Microscopic polyangiitis (MPA)
Granulomatosis with polyangiitis (GPA): previously known as Wegener’s granulomatosis
Eosinophilic granulomatosis with polyangiitis (EGPA): previously known as Churg-Strauss syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anti-GBM autoantibodies

A

Anti-GBM disease is a rare small-vessel vasculitis that results from the formation of GBM antibodies that target type IV collagen within the basement membrane. This results in linear deposition of IgG in the glomerular capillaries. Due to different pathogenesis, this condition is discussed differently to the ANCA-associated vasculitides.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The clinical presentation of glomerulonephritis can be highly variable.

A

Nephritic syndrome is a distinct clinical syndrome characterised by haematuria, variable proteinuria, renal impairment, and hypertension. However, this represents a single presentation that forms part of a spectrum of severity in patients with glomerulonephritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Presentation of glomerulonephritis is highly variable and may include:

A

Minimal haematuria and proteinuria
Acute self-limiting disease
Acute severe disease: severe renal impairment usually develops without treatment
Rapidly progressive glomerulonephritis: deterioration in renal function over days to weeks to a few months
Chronic kidney disease: slowly progressive deterioration in renal function due to inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

glomerulonephritis - symptoms

A

Lethargy
Recent infection: fever, sore throat, coryzal symptoms. Typical of poststreptococcal glomerulonephritis and IgA nephropathy
Haematuria
Oliguria: reduce urine output
Oedema: peripheral or periorbital
Shortness of breath: due to fluid overload
Haemoptysis: due to pulmonary haemorrhage (e.g. Anti-GBM, ANCA-vasculitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Signs -glomerulonephritis

A
Haematuria
Hypertension
Oedema: peripheral, periorbital
Fluid overload: raised JVP, bibasal crackles on auscultation, peripheral oedema, ascites
Reduce urine output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Extra-renal manifestations - glomerulonephritis

A

This refers to clinical features reflecting involvement of other organs systems. It is typically seen in patients with systemic causes (e.g. vasculitis, systemic lupus erythematosus, anti-GBM disease).

Skin: vasculitic rash (palpable purpura)
ENT: rhinosinusitis, nasal discharge, polychondritis (inflammation of cartilage)
Eyes: red, painful eyes (e.g. conjunctivitis, scleritis, uveitis)
Lungs: haemoptysis, pleuritic pain, wheeze
Heart: chest pain due to pericardial or myocardial involvement
Nervous system: mononeuropathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The diagnosis of nephritic syndrome is based on identification of…

A

Look for features supportive of haematuria of glomerular origin:

Dysmorphic red blood cells: red cell structure appears abnormal under the microscope
Red blood cell casts: identification of red bloods cells within urinary casts seen under the microscope. A cast is a microscopic cluster of particles wrapped in uromodulin (Tamm-Horsfall protein). Uromodulin is secreted by epithelial cells lining the loop of Henle, distal tubule & collecting duct.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Look for features supportive of haematuria of glomerular origin:

A

Dysmorphic red blood cells: red cell structure appears abnormal under the microscope
Red blood cell casts: identification of red bloods cells within urinary casts seen under the microscope. A cast is a microscopic cluster of particles wrapped in uromodulin (Tamm-Horsfall protein). Uromodulin is secreted by epithelial cells lining the loop of Henle, distal tubule & collecting duct.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Any patient with haematuria, proteinuria and declining renal function or evidence of an underlying disorder (e.g. new mononeuropathy or vasculitic rash) requires urgent assessment for suspected … In these patients a full renal screen should be requested and the majority of patients will need to undergo renal biopsy to confirm the underlying diagnosis.

A

Any patient with haematuria, proteinuria and declining renal function or evidence of an underlying disorder (e.g. new mononeuropathy or vasculitic rash) requires urgent assessment for suspected glomerulonephritis. In these patients a full renal screen should be requested and the majority of patients will need to undergo renal biopsy to confirm the underlying diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The management of nephritic syndrome depends on the underlying cause.

A

An accurate diagnosis of the underlying cause of nephritic syndrome is essential to offer specific treatments. Some causes of nephritic syndrome require aggressive immunosuppressive therapy, particularly the causes of rapidly progressive glomerulonephritis.

General supportive measures for acute kidney injury are required in all patients who can have significant renal impairment. Temporary renal replacement therapy (RRT) may be required while treatment is initiated and others may develop end-stage renal disease despite treatment.

17
Q

Complications

Nephritic syndrome

A

Nephritic syndrome can cause severe acute kidney injury and associated complications.

18
Q

The main complication associated with nephritic syndrome is renal impairment that may be severe and require…

A

The main complication associated with nephritic syndrome is renal impairment that may be severe and require RRT. In some cases, it is not possible to achieve renal recovery and patients require long-term RRT or transplantation. Many causes of nephritic syndrome are multisystem and can lead to widespread organ dysfunction. More specific complications depend on the underlying cause.

19
Q

Poststreptococcal glomerulonephritis occurs due to a prior infection with a…

A

Poststreptococcal glomerulonephritis occurs due to a prior infection with a group A beta-haemolytic Streptococcus.

20
Q

Poststreptococcal glomerulonephritis

Aetiology & pathophysiology

A

PSGN is usually associated with a recent skin or throat infection by Group A beta-haemolytic Streptococcus. After 1-3 weeks (longer for skin infection) patients develop features of glomerular disease, however the presentation is highly variable. Patients may be asymptomatic, have non-visible haematuria or develop acute severe nephritic syndrome.

The condition is thought to occur due to the development of immune complexes that contain streptococcal antigens. These get deposited within the renal glomeruli as the antibodies within the complexes cross-react with important glomerular structures due to ‘cross-reactivity’. This is known as molecular mimicry (similarity in antigen lead to autoreactivity) and causes an inflammatory response with development of glomerulonephritis.

21
Q

Diagnosis of Poststreptococcal glomerulonephritis (PSGN)

A

In children, the diagnosis is usually suspected by the development of features of glomerulonephritis (e.g. haematuria, proteinuria, renal impairment) with evidence of a recent streptococcal infection. The evidence for recent infection may be made by measuring antibody titres against specific components of streptococcus such as an anti-streptolysin titre (ASOT).

In adults, the diagnosis is made by renal biopsy that is almost always warranted in the presence of glomerulonephritis.

22
Q

Poststreptococcal glomerulonephritis (PSGN) treatment?

A

There is no specific treatment for PSGN and management is targeted at the complications (e.g. hypertension, oedema). In severe cases, renal replacement therapy is rarely needed. In children, resolution is usually rapid and long-term outcome excellent although the outcome in adults is more variable.

Evidence of active infection should be treated with antibiotics.

23
Q

Lupus nephritis refers to renal involvement in patients with systemic lupus erythematosus.

A

Lupus nephritis is a complex topic, which is classified based on the histological findings on renal biopsy. At its core, there is deposition of immune complexes within the glomeruli leading to a glomerular injury and a range of histological changes. Clinically, the presentation is highly variable and may present in a myriad of ways including both nephrotic syndrome and nephritic syndrome.

24
Q

Aetiology & pathophysiology

The pathophysiology of lupus nephritis is complex and involves a variety of mechanisms. Immune complexes form … and deposit within the renal glomeruli. Other immune components may be involved. The area of deposition varies and can include the mesangium, endothelium or epithelium. The clinical presentation is usually related to the location of deposition and immune reaction.

A

Aetiology & pathophysiology

The pathophysiology of lupus nephritis is complex and involves a variety of mechanisms. Immune complexes form due to anti-double-stranded DNA and deposit within the renal glomeruli. Other immune components may be involved. The area of deposition varies and can include the mesangium, endothelium or epithelium. The clinical presentation is usually related to the location of deposition and immune reaction.

25
Q

The diagnosis of lupus nephritis is typically made on renal biopsy completed in patients with known systemic lupus erythematosus (SLE) who develop haematuria, proteinuria and/or worsening renal function. Lupus nephritis may be the presenting feature of the SLE.

Lupus nephritis may be classified based on histological findings on renal biopsy.

A
Class I (minimal mesangial): rarely diagnosed as patients usually asymptomatic
Class II (mesangial proliferative): typically causes non-visible haematuria and proteinuria
Class III (focal): variable presentation. May have haematuria, proteinuria, renal impairment and/or nephrotic syndrome
Class IV (diffuse): most common and most severe form. May present with nephrotic or nephritic syndrome.
Class V (membranous): presents with nephrotic syndrome similar to membranous nephropathy
Class VI (advance sclerosis): global sclerosis and slowly worsening renal function
26
Q

The management depends on the underlying histological class. In patients with severe lupus nephritis (e.g. class IV) high dose systemic immunosuppression is typically require and patients may require renal replacement therapy.

A

The management depends on the underlying histological class. In patients with severe lupus nephritis (e.g. class IV) high dose systemic immunosuppression is typically require and patients may require renal replacement therapy.

27
Q

IgA nephropathy

A

IgA nephropathy is the most common primary chronic glomerular disease worldwide.

28
Q

IgA nephropathy

A

IgA nephropathy leads to deposition of IgA immunoglobulins within the glomeruli. This develops because galactose deficient IgA1 has an exposed N-acetylgalactosamine in the hinge region that is recognised by IgG and IgA1 leading to immune complex formation. IgA nephropathy commonly presents with visible haematuria or non-visible haematuria and proteinuria.

29
Q

ANCA-associated vasculitis

A

ANCA-associated vasculitis is an umbrella term for three small-vessel vasculitides characterised by ANCA autoantibodies.
ANCA-associated vasculitis is an umbrella term for three conditions:

Microscopic polyangiitis (MPA)
Granulomatosis with polyangiitis (GPA): previously known as Wegener’s granulomatosis
Eosinophilic granulomatosis with polyangiitis (EGPA): previously known as Churg-Strauss syndrome

30
Q

… disease is a rare small-vessel vasculitis.

A

Anti-glomerular basement membrane (Anti-GBM) disease is a rare small-vessel vasculitis.

31
Q

Anti-GBM disease

A

Anti-glomerular basement membrane (Anti-GBM) disease is a small vessel vasculitis with an annual incidence of one case per million population. It is characterised by the formation of anti-GBM antibodies that are directed against type IV collagen in the kidneys and lungs. This can lead to life-threatening glomerulonephritis and/or pulmonary haemorrhage.

Treatment requires potent immunosuppression and plasmapheresis that involves removing a patients plasma from the body and replacing it with another solution such as human albumin to remove the circulating autoantibodies.